13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 28 holding rows worth $379,902,000.
- Accession
- 0001493152-17-005309
- Filer
- CIK 1493215
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 28 entries on the cover page, a total value of $379,902,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $379,902,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.028-16671
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,092,516 | $55,991,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 623,330 | $47,392,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 570,692 | $31,034,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,028,929 | $30,714,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,458,120 | $29,048,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 572,689 | $28,004,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 1,216,505 | $23,479,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 908,733 | $18,674,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 4,245,882 | $16,007,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,305,643 | $12,848,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 82,490 | $11,026,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 612,903 | $9,494,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 103,617 | $9,419,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 80,900 | $7,545,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 566,230 | $7,321,000 | thousands by filing date | |
| VIVEVE MED INC | 92852W204 | COM NEW | 1,145,736 | $7,253,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,062,991 | $7,014,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 1,448,991 | $6,057,000 | thousands by filing date | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 287,876 | $5,455,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 1,446,587 | $4,701,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 515,612 | $4,388,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 470,167 | $3,738,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 26,183 | $965,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 241,699 | $873,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 1,283,951 | $648,000 | thousands by filing date | |
| SENSUS HEALTHCARE INC | 81728J109 | COM | 90,404 | $397,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 31,693 | $281,000 | thousands by filing date | |
| Sensus Healthcare, Inc @6.75 6 | 81728J117 | warrants | 155,000 | $136,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-17-005309 | this filing | 2017-05-15 | acceptance time not in the bulk data set |